发明名称 Intranasal oxytocin treatment to improve schizophrenia
摘要 The disclosure provides a method for enhancing memory of a subject, lowering blood glucose levels in a subject, and treating schizophrenia, the methods comprise intranasally administering to the subject an amount of a oxytocin peptide or analog thereof having a beneficial effect.
申请公布号 US9585935(B2) 申请公布日期 2017.03.07
申请号 US201113812850 申请日期 2011.07.30
申请人 The Regents of the University of California 发明人 Feifel David
分类号 A61K38/11;A61K9/00 主分类号 A61K38/11
代理机构 Gavrilovich, Dodd & Lindsey LLP 代理人 Baker, Jr. Joseph R.;Gavrilovich, Dodd & Lindsey LLP
主权项 1. A method of treating schizophrenia comprising chronically intranasally administering to a patient in need thereof an oxytocin peptide at a dose of about 40-100 IU per day.
地址 Oakland CA US